𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck

✍ Scribed by Sandrine Faivre; Adina Marti; Olivier Rixe; François Janot; Morbize Julieron; Michel Gatineau; Stéphane Temam; Jean-Pierre Armand; Christian Domenge; Bernard Luboinski; Eric Raymond

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
255 KB
Volume
27
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Induction chemotherapy may contribute to decreased local and distant recurrences in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) resectable for cure.

Methods.

Patients with previously untreated locally advanced stage III–IV (N0–2, M0) SCCHN received a dose‐dense sequential regimen combining cisplatin/5‐fluorouracil followed by bleomycin/methotrexate/hydroxyurea. Induction chemotherapy was followed by locoregional surgery and/or radiation therapy.

Results.

Among 37 patients, 23 (62%) had T4 primary tumors. Grade 3 to 4 asymptomatic hematologic toxicity occurred in less than 15% of patients. Nonhematologic toxicities were limited to grade 1 to 2 in less than 20% of patients. In the overall cohort (intent‐to‐treat; n = 35), 24 (68.5%) of 35 patients had objective clinical responses, including nine complete responses (25.7%). Fifty‐seven percent of patients were free of disease at 2.5 years.

Conclusions.

Sequential induction chemotherapy is feasible and active in patients with locally advanced head and neck cancers and may further include recent compounds such as taxanes. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005

📜 SIMILAR VOLUMES

Cost utility of docetaxel as induction c
Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck
✍ Anju Parthan; Marshall R. Posner; Caroline Brammer; Philippe Beltran; Jeroen P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

## Abstract ## Background Trial TAX 324 showed that induction chemotherapy with docetaxel plus cisplatin and 5‐fluorouracil (TPF) compared with cisplatin and 5‐fluorouracil (PF) followed by chemoradiation increases survival and time to progression in squamous cell carcinoma of head and neck (SCCHN

Surgical site infection after preoperati
Surgical site infection after preoperative neoadjuvant chemotherapy in patients with locally advanced oral squamous cell carcinoma
✍ Shih-An Liu; Yong-Kie Wong; Ching-Ping Wang; Chen-Chi Wang; Rong-San Jiang; Hui- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## Background We investigated whether preoperative neoadjuvant chemotherapy is associated with increased surgical site infection (SSI) rate in patients with locally advanced oral cancer. ## Methods In this hospital‐based study, we retrospectively reviewed over 2000 chart records of p

Cisplatin-5-fluorouracil chemotherapy fo
Cisplatin-5-fluorouracil chemotherapy for advanced inoperable squamous carcinoma of the head and neck
✍ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra 📂 Article 📅 1987 🏛 Wiley (John Wiley & Sons) ⚖ 368 KB 👁 1 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt

Microsatellite analysis and response to
Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma
✍ Hélène Blons; Arnauld Cabelguenne; Françoise Carnot; Ollivier Laccourreye; Isabe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 144 KB 👁 2 views

Molecular studies have revealed that microsatellite instability and loss of heterozygosity occurred in head-and-neck cancer, suggesting the involvement both of suppressor and of mutator pathways in head-and-neck carcinogenesis. There is evidence for relations between tumor phenotype and clinical par